Loratadine Arrow Conseil

Loratadine, the active ingredient in Loratadine Arrow Conseil, is a second‑generation H1 antagonist presented as an oral tablet for oral use. It alleviates symptoms of allergic rhinitis and chronic idiopathic urticaria in adults and children when appropriate. The drug works by selectively blocking peripheral histamine H1 receptors, reducing the vascular and sensory effects that cause itching, sneezing, and nasal congestion.

GNH USA supplies Loratadine Arrow Conseil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Loratadine is used to manage allergic conditions by antagonizing peripheral H1 receptors. - Allergic rhinitis: relief of sneezing, itching, rhinorrhea and nasal congestion. - Seasonal allergic rhinitis: control of symptoms triggered by pollen exposure. - Perennial allergic rhinitis: reduction of year‑round nasal allergy symptoms. - Chronic idiopathic urticaria: decrease in hives and associated itching.

Loratadine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate pain in the head. - Dry mouth: sensation of reduced salivation. - Fatigue: feeling of tiredness without exertion.

Serious or Rare Side Effects: - Anaphylaxis: severe, potentially life‑threatening allergic reaction. - Hepatotoxicity: signs of liver injury such as jaundice. - Cardiac arrhythmia: irregular heart rhythm, especially in patients with pre‑existing conditions.

When considering loratadine therapy, several safety aspects should be reviewed. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a physician. - Elderly patients: monitor for increased sedation or confusion. - Renal impairment: dose adjustment may be required. - Drug interactions: review concomitant medications for possible effects. - Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Loratadine can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Ketoconazole: may raise loratadine plasma concentrations. - Erythromycin: can increase loratadine levels. - Ritonavir: strong CYP3A4 inhibitor that elevates loratadine exposure.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance drowsiness. - Theophylline: loratadine may increase its plasma levels. - Other antihistamines: additive sedation may occur.